EU/3/15/1502
Table of contents
About
On 19 June 2015, orphan designation (EU/3/15/1502) was granted by the European Commission to Dr Ulrich Granzer, Germany, for trehalose for the treatment of spinocerebellar ataxia.
The sponsorship was transferred to FGK Representative Service GmbH, Germany in June 2020.
Key facts
Active substance |
Trehalose
|
Medicine name |
-
|
Disease / condition |
Treatment of spinocerebellar ataxia
|
Date of first decision |
19/06/2015
|
Outcome |
Positive
|
EU designation number |
EU/3/15/1502
|
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Sponsor's contact details
FGK Representative Service GmbH
Heimeranstrasse 35
Schwanthalerhoehe-Laim
80339 Munich
Germany
Bavaria
Tel: +498989311938
E-mail: Info@seelostx.com
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.